Wegovy GLP-1 injection pens on table

REGULATORY

12 Mar 2026

Medicare's GLP-1 Bridge: Who Gets In?

Medicare launches a temporary program giving eligible patients early, subsidized access to GLP-1 obesity drugs

Altimmune logo shown on tablet device screen

INNOVATION

6 Mar 2026

Altimmune's Liver Drug Moves Closer to the Finish Line

Altimmune confirms a 2026 Phase 3 launch for pemvidutide, backed by FDA Breakthrough Therapy status and $340M in capital

Biobank facility building with storage tanks and laboratory signage

TECHNOLOGY

4 Mar 2026

AI Maps Brown Fat Genes for Next-Gen Weight Drugs

AI uncovers fat-burning genes that could inspire a new class of obesity drugs targeting metabolism, not appetite

Scientist pipetting samples in biotech laboratory

INSIGHTS

2 Mar 2026

From Code to Clinic: AI Biotech Grows Up

AI drug developers face mounting pressure to turn machine learning breakthroughs into real clinical results

Merck corporate campus entrance with logo signage and office buildings

INNOVATION

25 Feb 2026

Can AI Rethink How New Drugs Are Found?

Alliance uses AI and clinical data to target IBD, dermatitis, and MS while cutting R&D risks

Doctor holding prescription bottle while speaking with patient

PARTNERSHIPS

24 Feb 2026

Lilly Deepens AI Push in Obesity Drug Race

US drugmaker expands Nimbus alliance to pursue oral therapy as analysts forecast $100bn market for weight-loss medicines

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.